Overview

Peak Inspiratory Flow (PIF) in COPD

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether PIF is clinically important when using the Ellipta DPI device. In addition, the study will validate the best/most clinically appropriate way to perform a PIF maneuver, to determine the testing capabilities of the preferred PIF maneuver and to relate this PIF measurement to meaningful clinical outcomes in COPD patients
Phase:
Phase 4
Details
Lead Sponsor:
Pulmonary Research Institute of Southeast Michigan
Collaborator:
GlaxoSmithKline
Treatments:
Albuterol